Horizon Discovery plc Операционная прибыль
Что обозначает Операционная прибыль в Horizon Discovery plc?
Операционная прибыль Horizon Discovery Group plc является -30.41%
Какое определение для Операционная прибыль?
Показатель относительной доходности компании - это отношение операционной прибыли, деленной на чистую выручку и выраженной в процентах.
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Операционная прибыль компаний в Health Care сектор на LSE по сравнению с Horizon Discovery plc
Что делает Horizon Discovery plc?
Horizon Discovery Group plc, a cell engineering company, engages in the design, manufacture, and application of gene editing and gene modulation tools in the United Kingdom, the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Screening, Research Reagents, Diagnostics, and BioProduction segments. It provides custom-made and off-the-shelf (OTS) RNAi gene modulation reagents, CRISPR reagents, synthetic SGRNAs, OTS cell models, and custom cell engineering services. The company also offers pooled CRISPR screens; arrayed RNAi and CRISPR screens, drug screens, and immunology assays; and RNAi and CRISPR screening libraries; and human T-Cell CRISPR screening service to meet the requirements of immunology based research in drug discovery. In addition, it provides OTS gene-edited CHO cells and custom CHO cell lines, and custom CHO gene engineering services; and OTS cell-based reference standards, made to order reference standards, and custom cell-based reference standards to evaluate molecular assays on a research use basis. The company serves customers in academic research labs, biopharmaceutical and diagnostics companies, and contract research and manufacturing organizations. It sells its products through direct field sales channel and e-commerce platform. The company has a partnership with the Rutgers, The State University of New Jersey to develop and commercialize base editing, a gene editing technology; strategic collaboration with Mammoth Biosciences to develop CRISPR tools to provide engineered cell lines for the biopharmaceutical industry; and collaboration with St George's University Hospital, London, and the European Molecular Genetics Quality Network to develop reference material for non-invasive prenatal testing. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom.
Компании с операционная прибыль похож на Horizon Discovery plc
- K2fly имеет Операционная прибыль из -30.56%
- China Shenghai Food имеет Операционная прибыль из -30.55%
- Thiru Arooran Sugars имеет Операционная прибыль из -30.55%
- Thiru Arooran Sugars имеет Операционная прибыль из -30.55%
- C&N имеет Операционная прибыль из -30.50%
- Goenka Diamond and Jewels имеет Операционная прибыль из -30.42%
- Horizon Discovery plc имеет Операционная прибыль из -30.41%
- SI-BONE Inc имеет Операционная прибыль из -30.39%
- SITO Mobile имеет Операционная прибыль из -30.34%
- SITO Mobile имеет Операционная прибыль из -30.34%
- @Health SA имеет Операционная прибыль из -30.33%
- Inogen Inc имеет Операционная прибыль из -30.32%
- Great Panther Mining имеет Операционная прибыль из -30.29%